IL48785A - Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases - Google Patents
Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseasesInfo
- Publication number
- IL48785A IL48785A IL48785A IL4878576A IL48785A IL 48785 A IL48785 A IL 48785A IL 48785 A IL48785 A IL 48785A IL 4878576 A IL4878576 A IL 4878576A IL 48785 A IL48785 A IL 48785A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- receptor blocking
- blocking compound
- beta
- alpha
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 3
- 230000000903 blocking effect Effects 0.000 title 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 title 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 title 1
- 210000001772 blood platelet Anatomy 0.000 title 1
- 208000029078 coronary artery disease Diseases 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7175 | 1975-01-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL48785A0 IL48785A0 (en) | 1976-03-31 |
| IL48785A true IL48785A (en) | 1978-08-31 |
Family
ID=4178628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL48785A IL48785A (en) | 1975-01-06 | 1976-01-05 | Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases |
Country Status (14)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0019006A1 (de) * | 1979-05-14 | 1980-11-26 | Ciba-Geigy Ag | Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung |
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| TW284688B (enrdf_load_html_response) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
| US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL37700A (en) * | 1970-10-02 | 1975-05-22 | Ciba Geigy Ag | Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative |
-
1975
- 1975-12-22 NZ NZ179623A patent/NZ179623A/xx unknown
- 1975-12-31 GB GB53300/75A patent/GB1510370A/en not_active Expired
-
1976
- 1976-01-02 CA CA242,899A patent/CA1063516A/en not_active Expired
- 1976-01-02 FR FR7600016A patent/FR2296430A1/fr active Granted
- 1976-01-02 DE DE19762600069 patent/DE2600069A1/de not_active Withdrawn
- 1976-01-05 IE IE11/76A patent/IE42766B1/en unknown
- 1976-01-05 BE BE163295A patent/BE837293A/xx unknown
- 1976-01-05 AU AU10002/76A patent/AU499140B2/en not_active Expired
- 1976-01-05 NL NL7600045A patent/NL7600045A/xx not_active Application Discontinuation
- 1976-01-05 IL IL48785A patent/IL48785A/xx unknown
- 1976-01-05 ZA ZA00760028A patent/ZA7628B/xx unknown
- 1976-01-05 ZA ZA00760026A patent/ZA7626B/xx unknown
- 1976-01-06 JP JP51000124A patent/JPS5191337A/ja active Pending
-
1980
- 1980-09-04 HK HK496/80A patent/HK49680A/xx unknown
-
1981
- 1981-12-30 MY MY159/81A patent/MY8100159A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK49680A (en) | 1980-09-12 |
| IE42766L (en) | 1976-07-06 |
| ZA7626B (en) | 1976-12-29 |
| JPS5191337A (enrdf_load_html_response) | 1976-08-10 |
| IL48785A0 (en) | 1976-03-31 |
| NL7600045A (nl) | 1976-07-08 |
| AU499140B2 (en) | 1979-04-05 |
| CA1063516A (en) | 1979-10-02 |
| ZA7628B (en) | 1976-12-29 |
| AU1000276A (en) | 1977-07-14 |
| IE42766B1 (en) | 1980-10-08 |
| MY8100159A (en) | 1981-12-31 |
| BE837293A (fr) | 1976-07-05 |
| GB1510370A (en) | 1978-05-10 |
| FR2296430B1 (enrdf_load_html_response) | 1978-11-10 |
| FR2296430A1 (fr) | 1976-07-30 |
| NZ179623A (en) | 1978-03-06 |
| DE2600069A1 (de) | 1976-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5233399A (en) | Patient*s respirator | |
| NL190448B (nl) | Geneesmiddel dat furocoumarine derivaten bevat voor fotochemische therapie. | |
| AU1285476A (en) | Human heart valve | |
| GB1540441A (en) | Treatment of blood plasma | |
| EG12353A (en) | Derivatives of alcoyloxy-5-phenyl-1-3-oxidiazoline-1,3,4 one-2,their preparation and their use as insecticides and acaricides | |
| JPS5246689A (en) | Heart pacemaker checking system | |
| NO152414C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider | |
| AU498717B2 (en) | Zirconium alloy heat treatment | |
| IL48785A (en) | Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases | |
| JPS5254286A (en) | Heart pacemaker | |
| Harris et al. | Dentofacial differences between “normal” sibs of Class II and Class III patients | |
| NO154795C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater. | |
| JPS5377073A (en) | Piperadine derivative compound and its production and medical drugs containing said compound | |
| JPS51139614A (en) | Medical suspension for gelatin capsullae | |
| HK74686A (en) | A process for the manufacture of novel benzazole derivatives,pharmaceutical preparations containing these derivatives,and their use | |
| IL48787A0 (en) | Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders | |
| ZA763081B (en) | Pharmaceutical preparations for the treatment of hyperuricacidemia | |
| NO147108C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-amino-lavere-alkyl-3,4-difenyl-1h-pyrazoler | |
| GB1541501A (en) | Implantable heart pacemaker | |
| NO144883C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-difenyl-3-(imidazolyl-1)-propener | |
| NO149889C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 1-piperazinyl-4h-s-triazolo(3,4c)tieno(2,3e)-1,4-diazepiner | |
| NO153652C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazin-derivater. | |
| PH12349A (en) | Treatment of seedlings | |
| AU506773B2 (en) | Compositions for treatment of cardiac rhythm disturbance | |
| JPS5271898A (en) | Improvement of blood dialyzer |